BCR::ABL1, JAK2, and STAT5A are all involved in progression of CML. Even if one pathway is suppressed, leukemic cells can still proliferate through other signaling pathways. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.